Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Beyond Herceptin and Gleevec.

Oliver M Fischer¹, Sylvia Streit, Stefan Hart

¹Max-Planck-Institute of Biochemistry, Department of Molecular Biology, Am Klopferspitz 18A, D-82152 Martinsried, Germany.

Current Opinion in Chemical Biology

|August 28, 2003

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Eliapixant is a selective P2X3 receptor antagonist for the treatment of disorders associated with hypersensitive nerve fibers.

Scientific reports·2021

Same author

Neuropeptide S receptor 1 is a nonhormonal treatment target in endometriosis.

Science translational medicine·2021

Same author

Correction: Lung cancer stem cells and their aggressive progeny, controlled by EGFR/MIG6 inverse expression, dictate a novel NSCLC treatment approach.

Oncotarget·2021

Same author

Retraction Notice to: The Cancer-Associated FGFR4-G388R Polymorphism Enhances Pancreatic Insulin Secretion and Modifies the Risk of Diabetes.

Cell metabolism·2020

Same author

Author Correction: Amine oxidase 3 is a novel pro-inflammatory marker of oxidative stress in peritoneal endometriosis lesions.

Scientific reports·2020

Same author

Amine oxidase 3 is a novel pro-inflammatory marker of oxidative stress in peritoneal endometriosis lesions.

Scientific reports·2020

Protein kinases are key cancer targets. Novel therapies, including monoclonal antibodies and small molecule ATP analogues, are emerging for targeted cancer treatment, offering new hope for patients.

Area of Science:

Oncology
Molecular Biology
Pharmacology

Background:

Protein kinases play a crucial role as oncoproteins in cancer development.
Target-directed therapies represent a significant advancement in cancer treatment.

Purpose of the Study:

To review novel therapeutic strategies targeting protein kinases.
To highlight the clinical development of agents targeting protein kinases.

Main Methods:

Development of humanized monoclonal antibodies against extracellular domains of transmembrane protein kinases.
Generation of small molecule ATP analogues targeting the kinase domain.

Main Results:

Successful clinical development of targeted therapies.

Related Experiment Videos

Approval of Herceptin for breast cancer and Gleevec for leukemia and GIST.

Conclusions:

Targeted therapies represent a novel and promising strategy in anti-cancer therapy.
These advancements signify a new era in personalized cancer medicine.